Your session is about to expire
← Back to Search
Procedure
Dilatation vs. Laser Resection for Tracheal Stenosis (AERATE Trial)
N/A
Recruiting
Led By Marc Fortin
Research Sponsored by Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
AERATE Trial Summary
This trial looks at whether endoscopic laser resection or dilatation is more effective in treating benign tracheal stenosis.
Who is the study for?
This trial is for adults over 18 with a simple, benign tracheal stenosis that's less than 1cm long and without cartilage damage. It's open to those getting their first treatment or having a recurrence but not to individuals with inflammation-related conditions, those unable to consent, or pregnant women.Check my eligibility
What is being tested?
The study compares two treatments for narrow airways due to benign tracheal stenosis: stretching the airway (dilatation) versus removing the blockage with a laser (endoscopic laser resection). Participants will be randomly assigned one of these treatments in multiple centers.See study design
What are the potential side effects?
Possible side effects may include discomfort at the site of treatment, bleeding, risk of infection, temporary breathing difficulties post-procedure, and potential need for additional procedures if narrowing recurs.
AERATE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Relapse rate at 2 years of symptomatic tracheal stenosis (> 40%) requiring a new procedure
Secondary outcome measures
Clinical COPD questionnaire
Measurement of stenosis by cephalo-caudal length at endoscopic follow-up at 1 year
Rate and type of complications and adverse effects depending on the procedure
+7 moreOther outcome measures
Relapse rate at 2 years of symptomatic tracheal stenosis (> 40%) requiring a new procedure in the idiopathic and non idiopathic subroup as well as in the first episode and recurrence subgroups
AERATE Trial Design
2Treatment groups
Experimental Treatment
Group I: Endoscopic laser resectionExperimental Treatment1 Intervention
Using CO2, diode or similar wavelenght laser the stenotic tracheal segment will be vaporized allowing a less than 20% residual stenosis. Dilatation will not be performed after laser resection for residual stenosis.
Group II: DilatationExperimental Treatment1 Intervention
Using a ballon or rigid bronchoscope the stenotic tracheal segment will be dilated with or without previous radial incision with electrocautery or laser.
Find a Location
Who is running the clinical trial?
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecLead Sponsor
36 Previous Clinical Trials
9,634 Total Patients Enrolled
Marc FortinPrincipal InvestigatorFondation IUCPQ
1 Previous Clinical Trials
120 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am unable to understand and give consent for treatment.My narrowing of passages is due to inflammation, possibly from a condition like granulomatosis with polyangiitis.I have a small, non-cancerous narrowing in my windpipe and am planning to have a procedure to open it.
Research Study Groups:
This trial has the following groups:- Group 1: Endoscopic laser resection
- Group 2: Dilatation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there any capacity remaining for participants in this experiment?
"Yes indeed, according to the clinicaltrials.gov portal this research is still seeking volunteers. The trial was set up on March 17th 2021 and its details were last amended May 2nd 2022; at present 108 individuals are sought from a single centre."
Answered by AI
To what extent has enrollment increased in this experiment?
"Affirmative, the clinical trial is currently recruiting. According to its page on clinicaltrials.gov, this study was initially posted on March 17th 2021 and last updated in May 2nd 2022. The recruitment process requires 108 patients from a single medical institution."
Answered by AI
Share this study with friends
Copy Link
Messenger